Checkpoint Inhibitor Monitoring AACR

June 8, 2019

Successful Monitoring of Checkpoint Inhibitors By Flow Cytometry, AACR 2019 

Successful-monitoring-of-checkpoint-inhibitors-by-flow-cytometry

Checkpoint Inhibitor Monitoring AACR

June 8, 2019

Successful Monitoring of Checkpoint Inhibitors By Flow Cytometry, AACR 2019 

Successful-monitoring-of-checkpoint-inhibitors-by-flow-cytometry

Flow Cytometry Compensation

April 22, 2019

Compensation Matters, But How Often? CYTO 2019

Flow Cytometry Compensation

April 22, 2019

Compensation Matters, But How Often? CYTO 2019

PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric Method

June 9, 2018

PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric Method, Keystone 2018

PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric

PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric Method

June 9, 2018

PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric Method, Keystone 2018

PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric

GLP Validation Cytokine Assay Cyto

June 9, 2018

Fit-for-Purpose GLP Validation of an Intra-Cellular Cytokine Staining Assay, CYTO 2018

GLP Validation Cytokine Assay Cyto

June 9, 2018

Fit-for-Purpose GLP Validation of an Intra-Cellular Cytokine Staining Assay, CYTO 2018

TILs Characterization Flow Cytometry

June 9, 2018

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery, ASCO 2018

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery

TILs Characterization Flow Cytometry

June 9, 2018

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery, ASCO 2018

Characterization of Two Potential Immunotherapeutics in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery